OncoMed Pharmaceuticals, Inc.
OMED
OMED was delisted on the 22nd of April, 2019.
55 hedge funds and large institutions have $200M invested in OncoMed Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 8 closing their positions.
108% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 12
30% more capital invested
Capital invested by funds: $154M → $200M (+$46.7M)
0% more funds holding
Funds holding: 55 → 55 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCI
Columbus Circle Investors
|
+$11.8M |
| 2 |
CCM
Cupps Capital Management
Chicago,
Illinois
|
+$4.34M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$4.3M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$2.99M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.69M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$3.39M |
| 2 |
TG
TCW Group
Los Angeles,
California
|
-$1.76M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.67M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$600K |
| 5 |
EMG
Ellington Management Group
Old Greenwich,
Connecticut
|
-$440K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CLOS
51
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| $50K | – | – | – |
|
52
AllianceBernstein
Nashville,
Tennessee
| $50K | +$47.2K | +1,400 | +1,918% |
|
|
PCM
53
Prelude Capital Management
New York
| $37K | +$37.1K | +1,100 | New |
|
54
Wells Fargo
San Francisco,
California
| $15K | +$5.05K | +150 | +49% |
|
55
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $145 | +$139K | +4,132 | +2,334% |
|
|
EMG
56
Ellington Management Group
Old Greenwich,
Connecticut
| – | -$440K | -14,900 | Closed |
|
57
Two Sigma Investments
New York
| – | -$300K | -10,172 | Closed |
|
58
Citadel Advisors
Miami,
Florida
| – | -$264K | -8,953 | Closed |
|
|
BJ
59
BlackRock Japan
Tokyo,
Japan
| – | -$159K | -5,393 | Closed |
|
|
TRCT
60
Tower Research Capital (TRC)
New York
| – | -$121K | -4,102 | Closed |
|
|
SO
61
STRS Ohio
Columbus,
Ohio
| – | -$64K | -1,900 | Closed |
|
|
QT
62
Quantbot Technologies
New York
| – | -$41K | -1,400 | Closed |
|
|
WEC
63
Winslow Evans & Crocker
Boston,
Massachusetts
| – | -$3K | -95 | Closed |
|
OMED Hedge Fund Activity: Q1 2014 in Review
55 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in OncoMed Pharmaceuticals, Inc. (OMED) for Q1 2014, worth a combined $200M — up 30% from $154M a quarter earlier.
Fund positioning in OMED was balanced in Q1 2014: 8 funds opened new positions, 8 closed out, 25 added to existing stakes and 12 trimmed.
The largest buyer was Columbus Circle Investors, adding an estimated $11.8M. The largest seller was BVF Inc, cutting an estimated $3.39M.
- 55 institutional investors held OncoMed Pharmaceuticals, Inc. (OMED) as of Q1 2014, unchanged from Q4 2013.
- Funds reported $200M of OncoMed Pharmaceuticals, Inc. stock for Q1 2014, up 30% quarter-over-quarter.
- 8 funds opened new OncoMed Pharmaceuticals, Inc. positions in Q1 2014 and 8 closed out, a net change of 0 holders.
- The largest OncoMed Pharmaceuticals, Inc. buyer in Q1 2014 was Columbus Circle Investors, an estimated $11.8M added.
- The largest OncoMed Pharmaceuticals, Inc. seller in Q1 2014 was BVF Inc, an estimated $3.39M sold.
Based on aggregated 13F filings for Q1 2014.